PracticeVideosBlogFlashcardsEspañol
All Practice Exams

Free Practice Questions for Egyptian Board Rheumatology & Rehab

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Same family resources

Explore More Egyptian Board Specialty Certifications (البورد المصري)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Egyptian Board — Anesthesia (Part 1 & 2)

Practice Questions

Egyptian Board — Cardiology (Part 1 & 2)

Practice Questions

Egyptian Board — Clinical Infectious Diseases (Part 1 & 2)

Practice Questions

Egyptian Board — Clinical Oncology (Part 1 & 2)

Practice Questions

Egyptian Board — Clinical Pathology (Part 1 & 2)

Practice Questions

Egyptian Board — Critical Care (Part 1 & 2)

Practice Questions

Sample Egyptian Board Rheumatology & Rehab Practice Questions

Try these sample questions to review concepts for the Egyptian Board Rheumatology & Rehab exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 48-year-old man presents with acute right knee pain and joint effusion. Arthrocentesis yields cloudy, low-viscosity synovial fluid. Laboratory analysis reveals a white blood cell (WBC) count of 38,000/μL with 82% polymorphonuclear leukocytes (PMNs), negative Gram stain, and no intracellular or extracellular crystals under polarizing microscopy. Which of the following synovial fluid categories does this aspirate represent?
A.Inflammatory synovial effusion
B.Non-inflammatory synovial effusion
C.Septic synovial effusion
D.Hemorrhagic synovial effusion
Explanation: Synovial fluid is categorized as inflammatory when the leukocyte count ranges between 2,000/μL and 50,000/μL (often extending up to 75,000/μL in crystal arthritis or rheumatoid flares) with >50% polymorphonuclear leukocytes and diminished viscosity. Non-inflammatory effusions typically exhibit <2,000 WBCs/μL with high viscosity. Septic effusions generally demonstrate WBC counts exceeding 50,000 to 100,000/μL with >90% PMNs, although lower counts can occur in early infection or immunosuppression.
2In the microanatomy of the normal synovial intimal lining, which characteristic feature correctly distinguishes type B synoviocytes from type A synoviocytes?
A.Expression of macrophage surface markers including CD68 and prominent phagocytic lysosomal vacuoles
B.Mesenchymal lineage expressing cadherin-11 and specialized secretion of high-molecular-weight hyaluronan and lubricin
C.Direct origin from circulating bone marrow-derived monocyte precursors that repopulate the synovial intima
D.Presence of well-developed basement membrane separating intimal synoviocytes from the vascular subintima
Explanation: Type B synoviocytes are fibroblast-like synoviocytes (FLSs) of mesenchymal origin that express vascular cell adhesion molecule-1 (VCAM-1) and cadherin-11, and they are responsible for synthesizing major joint lubricants including hyaluronan and lubricin (PRG4). In contrast, type A synoviocytes are tissue-resident macrophages derived from circulating bone marrow monocytes that express CD14 and CD68 and specialize in phagocytosis. The synovial intimal lining uniquely lacks a true epithelial basement membrane.
3Articular cartilage matrix exhibits unique biomechanical properties enabling friction-free load transmission. Which structural matrix component is primarily responsible for generating the high swelling pressure and compressive stiffness of healthy hyaline cartilage?
A.Type I collagen fibrils arranged in parallel bundles along the superficial tangential zone
B.Cross-linked elastin fibers dispersed throughout the pericellular and interterritorial matrices
C.Aggrecan monomers non-covalently bound to hyaluronic acid chains carrying dense negative charges
D.Fibronectin networks anchoring chondrocytes directly to the calcified subchondral tidemark
Explanation: Aggrecan is the primary large chondroitin sulfate proteoglycan of articular cartilage. Multiple aggrecan monomers non-covalently bind to a central hyaluronic acid backbone stabilized by link proteins, creating vast macromolecular aggregates. The densely packed negatively charged glycosaminoglycan side chains (chondroitin sulfate and keratan sulfate) attract mobile cations and water via the Donnan effect, generating hydrostatic swelling pressure that resists mechanical compression.
4Bone remodeling is tightly regulated by the triad of RANK, RANKL, and osteoprotegerin (OPG). Which molecular event directly promotes osteoclastogenesis and accelerated inflammatory bone resorption?
A.Binding of osteoprotegerin to RANK on hematopoietic myeloid osteoclast precursors
B.Suppression of membrane-bound RANKL expression on osteocytes by interleukin-1 and TNF-alpha
C.Cleavage of mature osteoclast vitronectin alpha-v-beta-3 integrins by synovial collagenases
D.Interaction of osteoblast- and osteocyte-derived RANKL with RANK receptors on osteoclast progenitor cells
Explanation: Receptor activator of nuclear factor-kappa B ligand (RANKL) is expressed by osteoblasts, osteocytes, and activated T cells. Binding of RANKL to its cognate receptor RANK on hematopoietic macrophage/osteoclast precursors recruits TRAF6, activating NF-kappa B and NFATc1 pathways to drive osteoclast differentiation, survival, and bone resorption. Osteoprotegerin (OPG) acts as a soluble neutralizing decoy receptor that prevents RANKL from binding to RANK.
5The 'shared epitope' hypothesis in rheumatoid arthritis refers to a conserved five-amino-acid sequence located within the antigen-binding groove of which human leukocyte antigen (HLA) molecule?
A.Residues 70 to 74 in the third hypervariable region of the HLA-DRB1 beta chain
B.Residues 9 to 13 in the alpha-1 domain helix of the HLA-B27 heavy chain
C.Residues 45 to 49 in the peptide-binding pocket of the HLA-DQB1 molecule
D.Residues 112 to 116 in the invariant cytoplasmic tail of the HLA-DR alpha chain
Explanation: The shared epitope is a five-amino-acid motif (QKRAA, QRRAA, or RRRAA) spanning positions 70 to 74 in the third hypervariable region of the HLA-DRB1 beta-1 chain (alleles such as *0401, *0404, *0101, and *1001). This basic sequence shapes the P4 peptide-binding pocket of the MHC Class II molecule, favoring the anchoring of citrullinated peptides (where neutral citrulline replaces positively charged arginine) for presentation to CD4+ helper T cells.
6Classical Rheumatoid Factor (RF) detected in clinical serological assays is most accurately defined as which type of autoantibody directed against which specific target?
A.An IgG autoantibody directed against the Fab fragment of human immunoglobulin M
B.An IgM autoantibody directed against the Fc portion of human immunoglobulin G
C.An IgA autoantibody directed against the variable heavy chains of circulating immune complexes
D.An IgE autoantibody directed against citrullinated filaggrin and vimentin epitopes
Explanation: Rheumatoid Factor (RF) is an autoantibody directed against the Fc fragment of human IgG. Although RF can belong to any immunoglobulin class (IgM, IgG, IgA), standard clinical laboratory assays (such as latex fixation and nephelometry) specifically measure IgM-isotype RF because its pentameric structure facilitates visible agglutination and strong classical complement fixation.
7The generation of anti-citrullinated protein antibodies (ACPA) involves post-translational deimination of peptide antigens. Which calcium-dependent enzyme is primarily responsible for converting peptidylarginine into peptidylcitrulline in inflamed mucosal tissues and joints?
A.Matrix metalloproteinase-9 (gelatinase B)
B.Transglutaminase-2 (tissue transglutaminase)
C.Peptidylarginine deiminase (notably PAD4 and PAD2)
D.Aggrecanase-1 (ADAMTS-4 metalloproteinase)
Explanation: Peptidylarginine deiminases (predominantly PAD2 and PAD4) are calcium-dependent intracellular enzymes released by dying neutrophils during NETosis (neutrophil extracellular trap formation) in response to tobacco smoke or periodontal pathogens like Porphyromonas gingivalis. PAD enzymes post-translationally deiminate positively charged arginine residues into neutral citrulline within proteins such as vimentin, fibrinogen, and alpha-enolase, creating neoepitopes that break immune tolerance.
8HLA-B27 is strongly linked to the pathogenesis of axial spondyloarthritis. Beyond classical peptide presentation, which aberrant molecular phenomenon of the HLA-B27 heavy chain triggers the unfolded protein response (UPR) and subsequent IL-23/IL-17 axis activation?
A.Premature lysosomal degradation driven by beta-2 microglobulin overexpression
B.Resistance to endosomal cleavage by cathepsin S in antigen-presenting dendritic cells
C.Irreversible competitive inhibition of killer-cell immunoglobulin-like receptors (KIR3DL1)
D.Misfolding of the heavy chain within the endoplasmic reticulum forming disulfide-linked homodimers
Explanation: The HLA-B27 heavy chain possesses a tendency to fold slowly and misfold within the endoplasmic reticulum (ER) due to a unique cysteine residue at position 67 (Cys67). This leads to the accumulation of misfolded heavy chains and disulfide-linked homodimers, triggering ER stress and the unfolded protein response (UPR). The UPR upregulates transcription of IL-23 by dendritic cells and macrophages, which subsequently drives Th17 and type 3 innate lymphoid cell (ILC3) expansion and entheseal inflammation.
9Which cell type within the inflamed rheumatoid synovium represents the predominant cellular source of tumor necrosis factor-alpha (TNF-alpha)?
A.CD68+ synovial tissue macrophages (type A synoviocytes)
B.CD20+ mature memory B lymphocytes
C.CD4+ Th2 helper T lymphocytes
D.Deep-zone articular chondrocytes
Explanation: Within the rheumatoid synovial sublining and lining layers, CD68+ tissue macrophages (type A synoviocytes) are the primary producers of TNF-alpha and interleukin-1. TNF-alpha acts in an autocrine and paracrine fashion to activate fibroblast-like synoviocytes, stimulate endothelial adhesion molecules (ICAM-1, VCAM-1), and induce secondary cytokine cascades including IL-6 and IL-8.
10Interleukin-6 (IL-6) signals via both 'classical' and 'trans-signaling' pathways. What distinct molecular feature characterizes IL-6 trans-signaling, which mediates the majority of chronic systemic inflammatory pathology?
A.Direct engagement of membrane-bound gp130 homodimers in the complete absence of any IL-6 receptor subunit
B.Binding of IL-6 to soluble IL-6 receptor (sIL-6R), enabling complex signaling in cells expressing only membrane gp130
C.Intracellular translocation of IL-6 to activate nuclear steroid hormone response elements without membrane receptors
D.Phosphorylation of the Janus kinase 3 (JAK3) pathway exclusively via membrane-tethered IL-6R on hepatocytes
Explanation: Classical IL-6 signaling is restricted to cells expressing membrane-bound IL-6R (hepatocytes, neutrophils, and certain lymphocytes). In contrast, IL-6 trans-signaling occurs when circulating IL-6 binds to soluble IL-6 receptor (sIL-6R), generated by alternative splicing or ADAM17 shedding. This IL-6/sIL-6R complex can then bind to and dimerize membrane gp130, which is ubiquitously expressed across virtually all cell types (including endothelial cells and synoviocytes), driving chronic inflammatory and destructive joint disease.

About the Egyptian Board Rheumatology & Rehab Exam

The Egyptian Board in Rheumatology and Physical Rehabilitation is the definitive postgraduate professional credential administered by the Egyptian Health Council (المجلس الصحي المصري) under Law No. 12 of 2022. It integrates clinical rheumatology, musculoskeletal medicine, electrodiagnostic medicine, and comprehensive physical rehabilitation. The examination pathway comprises three progressive phases: Part 1 written basic sciences and neuroanatomy, Part 2 written clinical rheumatology and physical medicine, and Part 3 comprehensive clinical OSCE, joint examination, EMG/NCS case review, and oral viva voce.

Exam sponsor: Egyptian Health Council (EHC) — Egyptian Board (المجلس الصحي المصري — البورد المصري). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The Egyptian Board Rheumatology and Rehabilitation examination comprises three distinct stages: Part 1 consists of written multiple-choice examinations assessing immunology, musculoskeletal anatomy, joint kinematics, and neurophysiology. Part 2 features advanced multiple-choice questions evaluating systemic connective tissue diseases, biological and targeted synthetic DMARDs, osteoporosis management, and neurorehabilitation algorithms. Part 3 is a comprehensive clinical examination consisting of objective structured clinical examination (OSCE) stations, bedside musculoskeletal physical examination (GALS/pGALS, detailed joint testing), EMG waveform interpretation, and oral viva voce with external examiners. Note that Part Three is entirely clinical, and the official board does not publish a standardized MCQ question count. This 100-question practice set is an English-language study aid dedicated to reinforcing key cognitive knowledge across Parts 1 and 2.

Time Limit

Varies by examination part

Passing Score

Set by psychometric standard-setting (Angoff/Hofstee method); no fixed percentage published

Exam / Certification Fees

Prescribed by Egyptian Health Council regulatory bylaws

Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

20%

Musculoskeletal Anatomy, Immunology & Biology of Connective Tissue

Functional anatomy and biomechanics of synovial joints and spine; synovial fluid mechanics; innate and adaptive immunity in autoimmune disease (HLA associations, autoantibodies, cytokine pathways: TNF, IL-6, IL-17/23, BAFF/APRIL); articular cartilage matrix biology; bone turnover and osteoclast/osteoblast signaling.

25%

Inflammatory Arthritis & Spondyloarthropathies

Rheumatoid arthritis (ACR/EULAR 2010 criteria, synthetic and targeted biologic DMARDs, JAK inhibitors, monitoring, extra-articular manifestations); axial and peripheral spondyloarthritis (ankylosing spondylitis, psoriatic arthritis, reactive arthritis, enteropathic arthritis); crystal-induced arthropathies (gout, CPPD, basic calcium phosphate); juvenile idiopathic arthritis (JIA).

25%

Systemic Autoimmune & Connective Tissue Diseases

Systemic lupus erythematosus (SLE ACR/EULAR criteria, lupus nephritis classification and induction/maintenance regimens, neuropsychiatric SLE, antiphospholipid syndrome); systemic sclerosis (limited vs diffuse, pulmonary arterial hypertension, interstitial lung disease, scleroderma renal crisis); idiopathic inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis, anti-synthetase syndrome); Sjögren syndrome; systemic vasculitides (large, medium, small vessel/ANCA-associated).

15%

Degenerative, Metabolic & Regional Musculoskeletal Disorders

Osteoarthritis (pathophysiology, conservative, pharmacological, and intra-articular interventions); osteoporosis (FRAX scoring, DEXA interpretation, antiresorptives, anabolic therapies); fibromyalgia and central sensitization; regional pain syndromes (rotator cuff tendinopathies, epicondylitis, carpal tunnel syndrome, plantar fasciitis).

15%

Physical Medicine, Rehabilitation & Electrodiagnosis

Electromyography (EMG) and nerve conduction studies (NCS) principles and interpretation; stroke rehabilitation, spinal cord injury rehab (ASIA impairment scale), and traumatic brain injury rehab; orthotics, prosthetics, and assistive devices; physical modalities (heat, cryotherapy, ultrasound, TENS); therapeutic exercise prescription.

Preparing for the Egyptian Board Rheumatology & Rehab Exam

What You Need to Know

  • Passing score: Set by psychometric standard-setting (Angoff/Hofstee method); no fixed percentage published
  • Assessment: The Egyptian Board Rheumatology and Rehabilitation examination comprises three distinct stages: Part 1 consists of written multiple-choice examinations assessing immunology, musculoskeletal anatomy, joint kinematics, and neurophysiology. Part 2 features advanced multiple-choice questions evaluating systemic connective tissue diseases, biological and targeted synthetic DMARDs, osteoporosis management, and neurorehabilitation algorithms. Part 3 is a comprehensive clinical examination consisting of objective structured clinical examination (OSCE) stations, bedside musculoskeletal physical examination (GALS/pGALS, detailed joint testing), EMG waveform interpretation, and oral viva voce with external examiners. Note that Part Three is entirely clinical, and the official board does not publish a standardized MCQ question count. This 100-question practice set is an English-language study aid dedicated to reinforcing key cognitive knowledge across Parts 1 and 2.
  • Time limit: Varies by examination part
  • Exam / certification fees: Prescribed by Egyptian Health Council regulatory bylaws Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Egyptian Board Rheumatology & Rehab: Suggested Study Strategy

1Master ACR/EULAR classification criteria and treatment guidelines for Rheumatoid Arthritis, SLE, Systemic Sclerosis, and Spondyloarthritis.
2Understand the mechanism of action, baseline screening (latent TB, hepatitis serology), and adverse effects of biologic agents (TNF, IL-6, IL-17, B-cell depleters) and JAK inhibitors.
3Review electromyography and nerve conduction study patterns for radiculopathy, plexopathy, focal entrapment neuropathies, and myopathies.
4Consolidate rehabilitation protocols for spinal cord injuries (ASIA scale), stroke recovery, and gait analysis biomechanics.

Frequently Asked Questions

What is the official question count for the Egyptian Board Rheumatology exam?

The Egyptian Health Council does not publish a fixed, standardized question count for its written examination stages. Parts 1 and 2 written papers typically range between 100 and 200 MCQs. This platform provides 100 curated practice MCQs covering core high-yield curriculum objectives.

Does this practice test evaluate practical clinical joint examination (Part 3)?

Part 3 is an in-person clinical and practical examination assessing physical joint examination, injection techniques, EMG interpretation, and oral viva. This practice test is dedicated to mastering the theoretical and diagnostic foundations tested in Parts 1 and 2.

What standard textbooks are recommended for Egyptian Board Rheumatology and Rehab?

Key recommended sources include Kelley and Firestein's Textbook of Rheumatology, Hochberg's Rheumatology, Braddom's Physical Medicine and Rehabilitation, and DeLisa's Physical Medicine and Rehabilitation.